[Studies into prostaglandin levels of amniotic fluid in early pregnancy (author's transl)]. 1981

J Nieder, and W Augustin

Equivalents of primary prostaglandins A and B as well as E and F were determined in the amniotic fluid of 64 clinically intact women in early pregnancy. The prostaglandin levels of the A and B groups were continuously lowered, between the ninth and 32nd weeks of pregnancy, while prostaglandin E revealed gradual rise from 57 pg/ml, in the ninth and tenth weeks, to 100 pg/ml, between the 29th and 32nd weeks. Prostaglandin F levels behaved similarly, between the 16th and 21st as well as between the 29th and 32nd weeks, mean values being 60 pg/ml or 75 pg/ml, respectively. High prostaglandin F levels, as recorded between the ninth and twelfth weeks of pregnancy (244 pg/ml), were probably attributable to mode by which amniotic fluid has been collected. Collection in that phase of pregnancy was transcervically, following cervix dilation during abortion, which differed from transabdominal amniocentesis in more advanced pregnancy. The above findings are discussed with regard to their physiological and clinical relevance.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011454 Prostaglandins A (13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid (PGA(1)); (5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid (PGA(2)); (5Z,13E,15S,17Z)-15-hydroxy-9-oxoprosta-5,10,13,17-tetraen-1-oic acid (PGA(3)). A group of naturally occurring secondary prostaglandins derived from PGE; PGA(1) and PGA(2) as well as their 19-hydroxy derivatives are found in many organs and tissues. PGA
D011456 Prostaglandins B Physiologically active prostaglandins found in many tissues and organs. They are potent pressor substances and have many other physiological activities. PGB
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Nieder, and W Augustin
October 1986, The Japanese journal of antibiotics,
J Nieder, and W Augustin
May 1974, Ceskoslovenska gynekologie,
J Nieder, and W Augustin
June 1986, Lancet (London, England),
J Nieder, and W Augustin
February 1981, Bratislavske lekarske listy,
J Nieder, and W Augustin
February 1980, Zeitschrift fur Geburtshilfe und Perinatologie,
J Nieder, and W Augustin
January 1979, Zentralblatt fur Gynakologie,
J Nieder, and W Augustin
December 1974, Zeitschrift fur Geburtshilfe und Perinatologie,
J Nieder, and W Augustin
January 1972, The Journal of obstetrics and gynaecology of the British Commonwealth,
J Nieder, and W Augustin
October 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!